Isabella Eckerle to Antibodies, Viral
This is a "connection" page, showing publications Isabella Eckerle has written about Antibodies, Viral.
Connection Strength
0.228
-
SARS-CoV-2 infection as a trigger of humoral response against apolipoprotein A-1. Eur J Clin Invest. 2021 Nov; 51(11):e13661.
Score: 0.023
-
Persistence of anti-SARS-CoV-2 antibodies: immunoassay heterogeneity and implications for serosurveillance. Clin Microbiol Infect. 2021 Nov; 27(11):1695.e7-1695.e12.
Score: 0.023
-
Novel SARS-CoV-2 variants: the pandemics within the pandemic. Clin Microbiol Infect. 2021 Aug; 27(8):1109-1117.
Score: 0.022
-
A high-throughput microfluidic nanoimmunoassay for detecting anti-SARS-CoV-2 antibodies in serum or ultralow-volume blood samples. Proc Natl Acad Sci U S A. 2021 05 04; 118(18).
Score: 0.022
-
Case Report: Stepwise Anti-Inflammatory and Anti-SARS-CoV-2 Effects Following Convalescent Plasma Therapy With Full Clinical Recovery. Front Immunol. 2021; 12:613502.
Score: 0.022
-
Daily Viral Kinetics and Innate and Adaptive Immune Response Assessment in COVID-19: a Case Series. mSphere. 2020 11 11; 5(6).
Score: 0.022
-
Diagnostic accuracy of Augurix COVID-19 IgG serology rapid test. Eur J Clin Invest. 2020 Oct; 50(10):e13357.
Score: 0.021
-
Validation of a commercially available SARS-CoV-2 serological immunoassay. Clin Microbiol Infect. 2020 Oct; 26(10):1386-1394.
Score: 0.021
-
Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based study. Lancet. 2020 08 01; 396(10247):313-319.
Score: 0.021
-
Serologic assessment of possibility for MERS-CoV infection in equids. Emerg Infect Dis. 2015 Jan; 21(1):181-2.
Score: 0.014
-
Definitions for coronavirus disease 2019 reinfection, relapse and PCR re-positivity. Clin Microbiol Infect. 2021 Mar; 27(3):315-318.
Score: 0.005
-
Validation and clinical evaluation of a SARS-CoV-2 surrogate virus neutralisation test (sVNT). Emerg Microbes Infect. 2020 Dec; 9(1):2394-2403.
Score: 0.005
-
Development and Validation of the Elecsys Anti-SARS-CoV-2 Immunoassay as a Highly Specific Tool for Determining Past Exposure to SARS-CoV-2. J Clin Microbiol. 2020 09 22; 58(10).
Score: 0.005